Skip to main content

Table 1 Main clinical features

From: Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!

Total patients

103

Male (%)

66 (64%)

Age (years), mean (± SD)

60.3 (±13.1)

Axonal sensory-motor polyneuropathy (%)

48 (46.6%)

Axonal sensory polyneuropathy (%)

45 (43.7%)

Demyelinating neuropathy (%)

10 (9.7%)

Sensory symptoms (%)

85 (82.5%)

Motor symptoms (%)

51 (49.5%)

Small fiber neuropathy (%)

5 (4.8%)

α-GAL A activity in males (mean (± SD)

26.4 nmol/L/h (± 12.6)

Patients with systemic symptoms or signs of FD (%)

9 (8.7%)